For nearly 35 years, musician Ani DiFranco has graced the world with her music. With more than 20 albums released to date, ...

Growth investors focus on stocks that are seeing above-average financial growth, as this feature helps these securities garner the market's attention and deliver solid returns. But finding a great ...

ANIP is expected to raise 2025 guidance due to FDA approval and launch of TEZRULY and INZIRQO, addressing unmet needs for ...

ANI Pharmaceuticals ANIP Get Free Report is gearing up to announce its quarterly earnings on Friday, 2025-05-09. Here's a ...

ANI Pharmaceuticals reports record Q1 2025 growth with strong generics, Cortrophin Gel demand, and raised revenue guidance.

The third annual Ani-May celebration kicked off this week, presented by Crunchyroll. Festivities are taking place worldwide ...

Increased 2025 guidance with expected net revenues of $768.0 million to $793.0 million, adjusted non-GAAP EBITDA of $195.0 ...

ANI expects full-year earnings in the range of $6.27 to $6.62 per share, with revenue in the range of $768 million to $793 million. ANI shares have climbed 29% since the beginning of the year. The ...

BAUDETTE, Minn. (AP) — BAUDETTE, Minn. (AP) — ANI Pharmaceuticals Inc. (ANIP) on Friday reported first-quarter earnings of $15.7 million. The Baudette, Minnesota-based company said it had ...